Reuters logo
BRIEF-Amgen submits regulatory applications for repatha cardiovascular outcomes data in US, Europe
June 5, 2017 / 1:12 PM / 4 months ago

BRIEF-Amgen submits regulatory applications for repatha cardiovascular outcomes data in US, Europe

June 5 (Reuters) - Amgen Inc:

* Amgen submits regulatory applications for repatha® (evolocumab) cardiovascular outcomes data in US and Europe Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below